Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Net Change in Cash : ¥-65.5 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hubei Biocause Heilen Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Hubei Biocause Heilen Pharmaceutical Co's Net Change in Cash for the three months ended in Mar. 2024 was ¥-31.2 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-65.5 Mil.

Hubei Biocause Heilen Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Hubei Biocause Heilen Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Biocause Heilen Pharmaceutical Co Net Change in Cash Chart

Hubei Biocause Heilen Pharmaceutical Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

8.62

39.89

1,754.35

-1.53

-163.76

Hubei Biocause Heilen Pharmaceutical Co Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-32.35	-1.69	1.35	-33.90	-31.23

Hubei Biocause Heilen Pharmaceutical Co Net Change in Cash Calculation

Hubei Biocause Heilen Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	137.063	+	-207.469	+	-97.168	+	3.81
	=	-163.8

Hubei Biocause Heilen Pharmaceutical Co's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 14.331 + -46.107 + 0 + 0.551

= -31.2

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-65.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Biocause Heilen Pharmaceutical Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Hubei Biocause Heilen Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Biocause Heilen Pharmaceutical Co Ltd (SZSE:301211) » Definitions » Net Change in Cash

Comparable Companies

SZSE:300683 SZSE:300158 SHSE:600351 SZSE:301509 SHSE:603367 SZSE:301089 SZSE:002793 SHSE:688553 SHSE:600789 SHSE:605199 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

N/A

Address

No. 122, Yangwan Road, Dadao District, Jingmen High-tech Zone, Hubei Province, Jingmen, CHN, 448000

Website

http://www.biocause.com

Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Headlines

No Headlines